These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3247817)

  • 21. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
    Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical studies of BH-AC-DMP in adult acute nonlymphocytic leukemia].
    Kato Y; Kawashima K; Ohno R; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1077-86. PubMed ID: 6582751
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of adult acute promyelocytic leukemia during the period of 1974-1982].
    Kawashima K; Nagura E; Kato Y; Suzuki H; Morishima Y; Ogura M; Watanabe E; Kodera Y; Ohno R; Sugihara T
    Rinsho Ketsueki; 1984 Feb; 25(2):121-8. PubMed ID: 6590879
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Kantarjian H
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New combination chemotherapy of adult acute nonlymphocytic leukemia].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K; Tanaka K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2314-21. PubMed ID: 2937862
    [No Abstract]   [Full Text] [Related]  

  • 27. [Double minute chromosomes (DMs) in a case of acute myelocytic leukemia (M2: FAB classification)].
    Oguma N; Maehama S; Dohy H; Takimoto Y; Kamada N; Kuramoto A; Tanaka K; Mandai K; Tahara E
    Rinsho Ketsueki; 1984 Jun; 25(6):856-63. PubMed ID: 6592372
    [No Abstract]   [Full Text] [Related]  

  • 28. Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene.
    Yokoyama Y; Suzukawa K; Okoshi Y; Nanmoku T; Obara N; Enami T; Hasegawa Y; Chiba S
    Ann Hematol; 2012 Sep; 91(9):1491-3. PubMed ID: 22307741
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acute leukemia].
    Amaki K
    Rinsho Ketsueki; 1984 Apr; 25(4):447-59. PubMed ID: 6540824
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of advanced myelodysplastic syndromes: trend toward more aggressive chemotherapy?
    Aul C; Schneider W
    Haematol Blood Transfus; 1990; 33():382-6. PubMed ID: 2323646
    [No Abstract]   [Full Text] [Related]  

  • 31. Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
    Keating MJ; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich EJ
    Leukemia; 1992; 6 Suppl 2():78-80. PubMed ID: 1578950
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.
    Bär BM; de Witte T; de Pauw BE; Haanen C
    Neth J Med; 1990 Feb; 36(1-2):19-24. PubMed ID: 2314517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Estey E; O'Brien S; Cortes J; Koller CA; Giles FJ; Kornblau S; Andreeff M; Vey N; Pierce SR; Hayes K; Wong GC; Keating M; Kantarjian H
    J Clin Oncol; 1999 Sep; 17(9):2819-30. PubMed ID: 10561358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress of chemotherapy in adult acute leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of leukemia].
    Niho Y
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):431-4. PubMed ID: 1607811
    [No Abstract]   [Full Text] [Related]  

  • 36. [Individualized chemotherapy of adult acute nonlymphocytic leukemia].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1473-80. PubMed ID: 2389943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonality switch in acute myeloid leukemia.
    Yin JA; Jowitt SN
    Leuk Lymphoma; 1996 Jun; 22(1-2):125-30. PubMed ID: 8724539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
    Bennett JM; Young MS; Liesveld JL; Paietta E; Miller KB; Lazarus HM; Marsh RD; Friedenberg WR; Saba HT; Hayes FA; Dewald GW; Hiddemann W; Rowe JM
    Am J Hematol; 2001 Jan; 66(1):23-7. PubMed ID: 11426487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone.
    Almeida AM; Pierdomenico F
    Leuk Res; 2012 Sep; 36(9):e211-3. PubMed ID: 22622173
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
    Ohshima T
    Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.